পদ্ধতির তুলনা করুন

	সমতা / অ-নিকৃষ্টতা পরীক্ষা	অভিযোজিত ক্লিনিক্যাল ট্রায়াল ডিজাইন
ক্ষেত্র	পরীক্ষামূলক নকশা	পরীক্ষামূলক নকশা
পরিবার	Hypothesis test	Hypothesis test
উদ্ভবের বছর	1987	1994
প্রবর্তক	Schuirmann, D.J. / EMA regulatory framework	Bauer & Köhne
ধরন	Parametric equivalence / non-inferiority test	Adaptive hypothesis test with interim analyses
মৌলিক উৎস	Schuirmann, D.J. (1987). A Comparison of the Two One-Sided Tests Procedure and the Power Approach. Journal of Pharmacokinetics and Biopharmaceutics, 15(6), 657–680.	Bauer, P. & Köhne, K. (1994). Evaluation of Experiments with Adaptive Interim Analyses. Biometrics, 50(4), 1029–1041.
অপর নাম	non-inferiority trial, bioequivalence study, active-control trial, Denklik ve Üstünlük Olmayan Çalışma (Equivalence / Non-Inferiority)	adaptive design, group sequential design, sample size re-estimation, platform trial
সম্পর্কিত	6	3
সারসংক্ষেপ	An equivalence or non-inferiority trial is a clinical study design that tests whether a new intervention is clinically equivalent to, or no worse than, an established standard by a pre-specified margin. Codified in Schuirmann's 1987 Two One-Sided Tests (TOST) framework and embedded in EMA and FDA regulatory guidance, this design is the regulatory standard for generic drug approval and medical device testing.	Adaptive clinical trial design is a flexible experimental framework, formalised by Bauer and Köhne in 1994, in which pre-specified rules allow the trial to be modified mid-course — adjusting sample size, treatment arms, or randomisation ratios — based on accumulating interim data while rigorously controlling the Type I error rate.